Owned by the Association for International Promotion & Study in Tumors (APSIT)
Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells
ERBB2 is overexpressed in up to 20–30% of human breast cancers (BCs), and it is associated with aggressive disease. Trastuzumab (Tz), a humanized monoclonal antibody, improves the prognosis associated with ERB...